期刊文献+

Beneficial effects of nutritional supplements on intestinal epithelial barrier functions in experimental colitis models in vivo 被引量:6

Beneficial effects of nutritional supplements on intestinal epithelial barrier functions in experimental colitis models in vivo
下载PDF
导出
摘要 Acute and chronic colitis affect a huge proportion of the population world-wide.The etiology of colitis cases can be manifold,and diet can significantly affect onset and outcome of colitis.While many forms of acute colitis are easily treatable,chronic forms of colitis such as ulcerative colitis and Crohn’s disease(summarized as inflammatory bowel diseases)are multifactorial with poorly understood pathogenesis.Inflammatory bowel diseases are characterized by exacerbated immune responses causing epithelial dysfunction and bacterial translocation.There is no cure and therapies aim at reducing inflammation and restoring intestinal barrier function.Unfortunately,most drugs can have severe side effects.Changes in diet and inclusion of nutritional supplements have been extensively studied in cell culture and animal models,and some supplements have shown promising results in clinical studies.Most of these nutritional supplements including vitamins,fatty acids and phytochemicals reduce oxidative stress and inflammation and have shown beneficial effects during experimental colitis in rodents induced by dextran sulphate sodium or 2,4,6-trinitrobenzene sulfonic acid,which remain the gold standard in pre-clinical colitis research.Here,we summarize the mechanisms through which such nutritional supplements contribute to epithelial barrier stabilization. Acute and chronic colitis affect a huge proportion of the population world-wide.The etiology of colitis cases can be manifold, and diet can significantly affect onset and outcome of colitis.While many forms of acute colitis are easily treatable, chronic forms of colitis such as ulcerative colitis and Crohn’s disease(summarized as inflammatory bowel diseases) are multifactorial with poorly understood pathogenesis.Inflammatory bowel diseases are characterized by exacerbated immune responses causing epithelial dysfunction and bacterial translocation.There is no cure and therapies aim at reducing inflammation and restoring intestinal barrier function.Unfortunately, most drugs can have severe side effects.Changes in diet and inclusion of nutritional supplements have been extensively studied in cell culture and animal models, and some supplements have shown promising results in clinical studies.Most of these nutritional supplements including vitamins, fatty acids and phytochemicals reduce oxidative stress and inflammation and have shown beneficial effects during experimental colitis in rodents induced by dextran sulphate sodium or 2,4,6-trinitrobenzene sulfonic acid, which remain the gold standard in pre-clinical colitis research.Here, we summarize the mechanisms through which such nutritional supplements contribute to epithelial barrier stabilization.
出处 《World Journal of Gastroenterology》 SCIE CAS 2019年第30期4181-4198,共18页 世界胃肠病学杂志(英文版)
基金 funded by the fund SEP-Cinvestav (Project 108) by Conacyt (284292) the Royal Society (NAF/R1/180017)
关键词 Colitis DEXTRAN sulphate sodium 2 4 6-trinitrobenzene sulfonic acid Tight JUNCTION Adherens JUNCTION PHYTOCHEMICALS BUTYRATE VITAMINS Short chain fatty acids MICRONUTRIENTS Colitis Dextran sulphate sodium 2,4,6-trinitrobenzene sulfonic acid Tight junction Adherens junction Phytochemicals Butyrate Vitamins Short chain fatty acids Micronutrients
  • 相关文献

参考文献3

二级参考文献20

  • 1MacDonald TT, Monteleone G, Pender SL. Recent develop- ments in the immunology of inflammatory bowel disease. Scand J Immunol 2000; 51:2-9.
  • 2Elson CO, Cong Y, Weaver CT, Schoeb TR, McClanahan TK, Fick RB, Kastelein RA. Monoclonal anti-interleukin 23 reverses active colitis in a T ceil-mediated model in mice. Gastroenterology 2007; 132:2359-2370.
  • 3Schreiber S, Khaliq-Kareemi M, Lawrance IC, Thomsen OO, Hanauer SB, McColm J, Bloomfield R, Sandborn WJ.Maintenance therapy with certolizumab pegol for Crohn's disease. N Engl J Med 2007; 357:239-250.
  • 4Takesue Y, Ohge H, Uemura K, Imamura Y, Murakami Y, Yokoyama T, Kakehashi M, Sueda T. Bacterial translocation in patients with Crohn's disease undergoing surgery. Dis Colon Rectum 2002; 45:1665-1671.
  • 5Shen L, Su L, Turner JR, Mechanisms and functional impli- cations of intestinal barrier defects. Dig Dis 2009; 27:443-449.
  • 6Muhlbauer M, Cheely AW, Yenugu S, Jobin C. Regulation and functional impact of lipopolysaccharide induced Nod2 gene expression in the murine epididymal epithelial cell line PC1. Immunology 2008; 124:256-264.
  • 7Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, Mc- Cormick BA, Podolsky DK. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003; 124:993-1000.
  • 8Okumura S, Yuki K, Kobayashi R, Okamura S, Ohmori K, Saito H, Ra C, Okayama Y. Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells. Clin Immunol 2009; 130:175-185.
  • 9Summers RW, Elliott DE, Urban JF, Thompson R, Wein- stock JV. Trichuris suis therapy in Crohn's disease. Gut 2005; 54:87-90.
  • 10Elliott DE, Li J, Blum A, Metwali A, Qadir K, Urban JF, Weinstock JV. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 2003; 284:G385-G391.

共引文献84

同被引文献54

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部